Paul Goddard, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 5,000 shares at $92.67 ($465K) on 2013-05-01, disclosed to the SEC on 2013-05-03.
Scheduled sale ($465k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.67 | 3,000 | $278K | 59.8% |
| 2 | $93.02 | 800 | $74K | 16.0% |
| 3 | $93.85 | 1,000 | $94K | 20.2% |
| 4 | $94.08 | 200 | $19K | 4.0% |
| Total | $93.02 avg | 5,000 | $465K | 100% |
| Filing → |
| ONXX | SELL | 2013-04-11 | $190K | — | Filing → |
| ONXX | SELL | 2013-03-11 | $85K | — | Filing → |
| ONXX | SELL | 2013-03-05 | $297K | — | Filing → |